SBIR/STTR Research Award

VULNERABLE PLAQUE DIAGNOSTIC HEAT DETECTOR

Award identifier cefe4c1cb710a4ed431177d1826d60b9a40d3c8e2bf81ff26151595275c69e6bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$120,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IMETRX, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

The objective of this proposal is to develop an intravascular thermal detector to identify vulnerable coronary artery plaque, which causes acute coronary artery diseases such as: unstable angina, acute myocardial infarction, and sudden cardiac death. The detector will work by sensing small temperature changes between inflamed vulnerable plaque and the neighboring healthy blood vessel wall. This guideware/catheter system for blood vessel surveying will provide a means for diagnosing and then treating vulnerable plaque, which are too small to be detected by angiography, before the plaque rupture and cause the current 70% of heart attacks that are now attributed to them. Coronary angiography is unable to define the status of the atheroma, and only measures the luminal dimensions of the blood vessel, without providing information about plaque content. We have developed a prototype thermal sensor for detecting the small temperature changes associated with vulnerable plaque. In the first phase of this program we will test the efficacy of various sensor designs using an ex vivo blood vessel model in order to converge on a preferred design and test in vivo the safety of the preferred design. In Phase II a complete prototype Thermal Profiling System will be fabricated and evaluated using animal models. PROPOSED COMMERCIAL APPLICATIONS: The commercial and medical value of a device that can enable preemptive treatment of coronary artery disease is self evident. Over 2 million catheterization diagnostic procedures are performed annually worldwide that would immediately quality for augmentation with catheter based diagnosis of vulnerable plaque.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.